Was Jim Cramer Right About Mind Medicine (MNMD) Stock?
Back in 2024, on May 14, a caller brought up Mind Medicine (MindMed) Inc. (NASDAQ:MNMD), a biotech company focused on psychedelic treatments for mental health. Cramer said he was supportive back then, particularly of companies tackling pain and addiction: …